Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016
Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016
New York, New York, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss | Acoustic Trauma, Ear Diseases, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Vestibular Dysfunction, hearing disorder, hearing loss disorder, nervous system disorder, noise induced hearing loss, otorhinolaryngologic disease, sudden sensorineural hearing loss, tinnitus | Enrolling by invitation | Early phase 1 | 2026-03-16 | NCT07472023 | |
| Evaluation of In-Vitro Cryo Therapeutic Protocols on Human Cell Samples (TWH-CRYO-001) | Biomechanical Injury Modeling (In-Vitro); Blunt Force Injuries to the Extremities (Cellular Injury Model); Cellular Injury and Post-Cryogenic Recovery; Cellular Regeneration and Repair; Cold-Induced Cellular Injury; Cryogenic Cellular Stress; Hypothermic Tissue Stress; Osmotic Stress Injury; Post-Thaw Viability Impairment; Thermal Injury Response; Tissue Damage and Recovery Pathways | Enrolling by invitation | Early phase 1 | 2026-01-06 | NCT07321028 | |
| Healthcare Integrity & Anti-Fraud Enforcement | Governance Failures; Healthcare Fraud Schemes; Kickback Networks; Public Transparency & Auditability; Regulatory Escalation Pathways; Supply Chain Vulnerabilities; Validator Oversight & DAO Governance; Whistleblower Activation | Enrolling by invitation | Not stated | 2025-10-20 | NCT07217730 | |
| Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings | Clinical Workflow Optimization; ESG-linked Healthcare Robotics Deployment; Mobility Impairment; Sanitation Protocol Compliance | Enrolling by invitation | Phase 2 | 2025-10-20 | NCT07214896 |